CDRE Q2 Deep Dive: M&A, Nuclear Momentum, and Public Safety Demand Drive Guidance Up

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CDRE Cover Image

Aerospace and defense company Cadre (NYSE: CDRE) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 31.8% year on year to $207.1 million. The company’s full-year revenue guidance of $759 million at the midpoint came in 2.9% above analysts’ estimates. Its non-GAAP profit of $0.48 per share was 50.9% above analysts’ consensus estimates.

Is now the time to buy CDRE? Find out in our full research report (it’s free for active Edge members).

Cadre (CDRE) Q2 CY2026 Highlights:

  • Revenue: $207.1 million vs analyst estimates of $178.2 million (31.8% year-on-year growth, 16.3% beat)
  • Adjusted EPS: $0.48 vs analyst estimates of $0.32 (50.9% beat)
  • Adjusted EBITDA: $41.99 million vs analyst estimates of $30.82 million (20.3% margin, 36.2% beat)
  • The company lifted its revenue guidance for the full year to $759 million at the midpoint from $747 million, a 1.6% increase
  • EBITDA guidance for the full year is $141.5 million at the midpoint, above analyst estimates of $136.9 million
  • Operating Margin: 10.8%, up from 9.3% in the same quarter last year
  • Market Capitalization: $1.41 billion

StockStory’s Take

Cadre’s second quarter results were met with a notably positive market reaction, as the company delivered strong top-line and margin expansion. Management attributed this performance to robust demand for mission-critical safety products, including law enforcement, first responder, and nuclear applications. CEO Warren Kanders pointed to the company’s “record orders backlog and continued momentum,” highlighting wins such as a follow-on contract for the U.S. military’s Blast Exposure Monitoring program and a key FBI armor contract, which underscored Cadre’s ability to secure high-value, multi-year agreements across its core markets.

Looking forward, Cadre’s updated guidance reflects management’s confidence in both organic and acquisition-driven growth for the remainder of the year. President Brad Williams emphasized the contribution of recent acquisitions, such as Alien Gear and TYR Tactical, as well as a growing backlog in the nuclear segment, particularly from commercial energy and environmental remediation projects. CFO Blaine Browers noted that the pipeline for additional M&A remains robust, and that the company’s financial flexibility positions it to pursue further strategic investments. Management stated, “We have greater scale, a more diversified portfolio and an expanding set of organic and inorganic growth opportunities.”

Key Insights from Management’s Remarks

Management linked the quarter’s outperformance to robust demand in core safety segments, a healthy contribution from recent acquisitions, and a record backlog that provides forward visibility.

  • Public safety demand strength: Management cited strong recurring demand across law enforcement and first responder markets, with new product wins such as the SXHP ballistic panel for the FBI broadening Cadre’s reach within key federal agencies.

  • Nuclear segment growth: The nuclear vertical saw increased backlog, driven by commercial nuclear energy projects and long-term environmental remediation in the U.S. and Europe. Management highlighted that national defense modernization and rising power demand from data centers are supporting multi-year investment cycles in nuclear safety.

  • M&A execution: The acquisition of Alien Gear and integration of TYR Tactical contributed meaningfully to the quarter’s results. Management described Alien Gear as exceeding expectations and noted ongoing synergies from combining product lines and manufacturing operations.

  • Distribution normalization: After a period of softness in discretionary product demand, Cadre’s distribution segment returned to organic growth, helping drive top-line expansion toward the high end of its targeted range.

  • Backlog visibility: A record orders backlog, led by wins in explosive ordnance disposal (EOD) and sensors, provides confidence in maintaining above-average growth rates in the coming quarters. Management noted that even after excluding outsized EOD wins, backlog growth was broad-based across armor, duty gear, and nuclear.

Drivers of Future Performance

Cadre expects continued revenue and margin expansion, supported by a combination of organic growth, backlog-driven execution, and contributions from recent acquisitions.

  • Sustained public safety momentum: Management expects ongoing demand from law enforcement and public safety customers, supported by new product launches and multi-agency contracts. The company’s pipeline includes additional large opportunities in armor, duty gear, and sensors, with demand described as resilient even in periods of municipal budget pressure.

  • Nuclear tailwinds and backlog: The nuclear segment is positioned for growth, with backlog gains from commercial energy, environmental remediation, and national defense projects. Management noted that U.S. government funding for nuclear modernization and cleanup provides multi-year demand visibility, though segment margins may fluctuate quarter-to-quarter due to project mix.

  • M&A pipeline and integration: Additional acquisitions are anticipated in the second half of the year, with the company focused on complementary businesses offering recurring revenue and strong margins. Management highlighted that realized synergies from Alien Gear and TYR Tactical should lift long-term profitability, and financial flexibility supports further inorganic expansion.

Catalysts in Upcoming Quarters

In the coming quarters, our team will monitor (1) integration milestones and margin improvement from the Alien Gear and TYR Tactical acquisitions, (2) continued backlog conversion, especially in nuclear and public safety segments, and (3) the cadence of large contract awards in both U.S. and international markets. Additional M&A announcements or unexpected shifts in government procurement timelines could also materially influence Cadre’s outlook.

Cadre currently trades at $33.10, up from $31.03 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

Our Favorite Stocks Right Now

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  277.29
+2.81 (1.02%)
AAPL  307.17
-6.16 (-1.97%)
AMD  475.99
-7.38 (-1.53%)
BAC  63.76
+0.59 (0.93%)
GOOG  354.58
+1.11 (0.31%)
META  595.06
+2.96 (0.50%)
MSFT  505.93
+5.94 (1.19%)
NVDA  219.17
-4.79 (-2.14%)
ORCL  151.38
+4.36 (2.97%)
TSLA  329.63
+1.05 (0.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.